All Articles

A new partnership between Flexzo Ai and Maiden Lane Medical signals a major shift, using AI not just for efficiency but as a cure for the clinician shortage.

Infinity Natural Resources adds M&A architect Timothy Dugan to its board, a move analysts see as a clear signal of the shale driller's growth ambitions.

The cord blood pioneer reported a 56% profit surge despite a revenue dip. But a key dispute with Duke University has halted its ambitious expansion into therapy.

Despite currency headwinds, Karooooo posted record subscriber growth. Our analysis unpacks the operational strategy turning investment into market dominance.

Matson posts stellar Q2 results fueled by its China service, but a closer look reveals a complex picture with weaker domestic volumes and shifting logistics.

With a new NYSE ticker and a combined portfolio of Mexican gold assets, the merger of Goldgroup and GRC creates a significant new player for investors.

As EverQuote prepares its Q2 2026 report, the market watches closely. Will its AI-powered growth engine justify its ambitious vision for the P&C sector?

As Applied Digital prepares its year-end report, all eyes are on the data center builder. Can it sustain its explosive growth and justify its massive bets on AI?

The firm reported a Q4 loss but a record $111M backlog fuels its ambitious plan for $150M revenue and a pivot to high-growth quantum and defense markets.

As Celldex nears pivotal data for its lead drug, the planned retirement of its long-serving CFO marks a strategic pivot toward becoming a commercial powerhouse.

A $50,000 donation is just the start. Discover how Earth's Best is tackling a systemic crisis, empowering consumers to help NYC's 154,000 homeless students.

Parse Biosciences, QIAGEN's strategic acquisition, just partnered with Australia's Garvan Institute. It's more than science—it's a calculated play to win.

A new deal between biosolutions giant Novonesis and innovator TurtleTree aims to mass-produce a vital milk protein, signaling a tectonic shift for the nutrition industry.

S&P's new rating for Constellation Insurance isn't just a grade; it's the capstone on a multi-year overhaul, offering a model for stability in a shifting market.

A new scholarship by healthcare exec Keith Myers aims to fight bigotry, but a recent federal settlement raises questions about its founder's own record.

BC3 Technologies is seeing 500% growth with its FDA-cleared hemostatic spray. A deep dive into the innovation, market adoption, and local economic boom.

The Department of War has suspended its flagship CMMC cybersecurity program, leaving thousands of contractors who invested heavily in compliance in a state of costly uncertainty.

A struggling Atlanta mall finds new life as a sprawling Emory Healthcare campus, thanks to a $95M deal and an innovative non-profit's charitable lease model.

DNRS, a brain retraining program, has shed its fragmented legacy system. We analyze how 9thCO's composable architecture provides a blueprint for commercial success.

A bold new venture aims to reconstruct war-torn nations, but can it overcome the immense geopolitical risks, crippling sanctions, and corporate mystery?